Deucravacitinib Long-term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s243, 2023. DOI: 10.25251/skin.7.supp.243. Disponível em: https://skin.dermsquared.com/skin/article/view/2358. Acesso em: 13 apr. 2025.